We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Lezra

- Antineoplastic
- Specialty

Product TA: Antineoplastic

Active Ingredient: Letrozole

Route Of Administration: Oral

Product type: Specialty

Product Details

Specialty: Oncology

Strength: 2.5 mg

Product Form: Tablet

Registration Number: DKI1331701517A1

Additional products

Plaxat

Product TA: Antineoplastic
Active Ingredient: Oxaliplatin
Route Of Administration: IV
Product type: Specialty

Tinibat

Product TA: Antineoplastic
Active Ingredient: Imatinib
Route Of Administration: Oral
Product type: Specialty

Page Last Updated: 05 October 2021